Metabolomics of volatile organic compounds in cystic fibrosis patients and controls

Pediatric Research

Volumn 68, Issue 1, 2010, Pages 75-80

  Robroeks, Charlotte M H H T ^a   Van Berkel, Joep J B N ^c   Dallinga, Jan W ^c   Jöbsis, Quirijn ^a   Zimmermann, Luc J I ^b   Hendriks, Han J E ^a   Wouters, Miel F M ^a   Van Der Grinten, Chris P M ^a   Van De Kant, Kim D G ^a   Van Schooten, Frederik Jan ^c   Dompeling, Edward ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Departments of Pediatrics   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTEN 1 OL; 3,3 DIMETHYLHEX 1 ENE; ACTIVATED CARBON; ANTACID AGENT; ANTIBIOTIC AGENT; BENZOTHIAZOLE; C12 SATURATED HYDROCARBON; C13 SATURATED HYDROCARBON; C16 POLYUNSATURATED HYDROCARBON; C8H16 HYDROCARBON; DEOXYRIBONUCLEASE; IMMUNOGLOBULIN E; LONG CHAIN ALKYLBENZENE; N METHYL 2 METHYLPROPYLAMINE; STEROID; TOLUALDEHYDE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BREATH ANALYSIS; CANDIDA ALBICANS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; ECZEMA; FEMALE; FORCED EXPIRATORY VOLUME; GAS CHROMATOGRAPHY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPUTUM; STAPHYLOCOCCUS AUREUS; TIME OF FLIGHT MASS SPECTROMETRY; VITAL CAPACITY; BREATHING; CHEMISTRY; CROSS-SECTIONAL STUDY; EVALUATION STUDY; MASS FRAGMENTOGRAPHY; METABOLISM; MICROBIOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLOMICS; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY OF RESULTS; RESPIRATION; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 77953812342     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181df4ea0     Document Type: Article

References (27)

1. Gibson RL, Burns JL, Ramsey BW 2003 Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918-951
2. Paredi P, Kharitonov SA, Barnes PJ 2000 Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 162:1450-1454
3. Horvath I, MacNee W, Kelly FJ, Dekhuijzen PN, Phillips M, Doring G, Choi AM, Yamaya M, Bach FH, Willis D, Donnelly LE, Chung KF, Barnes PJ 2001 "Hae-moxygenase-1 induction and exhaled markers of oxidative stress in lung diseases," summary of the ERS Research Seminar in Budapest, Hungary, September 1999. Eur Respir J 18:420-430
4. American Thoracic Society; European Respiratory Society 2005 ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171:912-930
5. Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, Jöbsis Q, Dompeling E, Wouters EF, van Schooten FJ 2010 Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy 40:68-76
6. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ 2009 Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076-1082
7. Delfino RJ, Gong H, Linn WS, Hu Y, Pellizzari ED 2003 Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. J Expo Anal Environ Epidemiol 13:348-363
8. Dragonieri S, Schot R, Mertens BJ, Le Cessie S, Gauw SA, Spanevello A, Resta O, Willard NP, Vink TJ, Rabe KF, Bel EH, Sterk PJ 2007 An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 120:856-862
9. Miekisch W, Schubert JK, Noeldge-Schomburg GF 2004 Diagnostic potential of breath analysis\focus on volatile organic compounds. Clin Chim Acta 347:25-39
10. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA, Rom WN 2003 Detection of lung cancer with volatile markers in the breath. Chest 123:2115-2123 (Pubitemid 36706741)
11. Shwachman H, Kulczycki LL 1958 Long-term study of one hundred five patients with cystic fibrosis; studies made over a five-to fourteen-year period. AMA J Dis Child 96:6-15
12. Burney P, Chinn S, Jarvis D, Luczynska C, Lai E; on behalf of the European Community Respiratory Health Survey 1996 Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 9:687-695
13. Stein SE, Scott DR 1994 Optimization and testing of mass-spectral library search algorithms for compound identification. J Am Soc Mass Spectrom 5:859-866
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC 1993 Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J (suppl 16):5-40
15. Edwards TL, Torstensen E, Dudek S, Martin ER, Ritchie MD 2010 A cross-validation procedure for general pedigrees and matched odds ratio fitness metric implemented for the multifactor dimensionality reduction pedigree disequilibrium test. Genet Epidemiol 34:194-199
16. Penn DJ, Oberzaucher E, Grammer K, Fischer G, Soini HA, Wiesler D, Novotny MV, Dixon SJ, Xu Y, Brereton RG 2007 Individual and gender fingerprints in human body odour. J R Soc Interface 4:331-340
17. Ambroise C, McLachlan GJ 2002 Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA 99:6562-6566
18. van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen E, Wouters EF, van Schooten FJ 2008 Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J Chromatogr B Analyt Technol Biomed Life Sci 861:101-107
19. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, McVay WP 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353:1930-1933
20. Phillips M, Cataneo RN, Condos R, Ring Erickson GA, Greenberg J, La Bombardi V, Munawar MI, Tietje O 2007 Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) 87:44-52 (Pubitemid 44960164)
21. Barker M, Hengst M, Schmid J, Buers HJ, Mittermaier B, Klemp D, Koppmann R 2006 Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J 27:929-936
22. Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, Mazzone PJ, Mekhail T, Jennings C, Stoller JK, Pyle J, Duncan J, Dweik RA, Erzurum SC 2005 Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 171:1286-1291
23. Mazzone PJ, Hammel J, Dweik R, Na J, Czich C, Laskowski D, Mekhail T 2007 Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 62:565-568
24. Kharitonov SA, Barnes PJ 2001 Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1722
25. McGrath LT, Mallon P, Dowey L, Silke B, McClean E, McDonnell M, Devine A, Copeland S, Elborn S 1999 Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 54:518-523
26. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F 1998 Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 78:49-53
27. Brown RK, Wyatt H, Price JF, Kelly FJ 1996 Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9:334-339